Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu • (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.

Serving underrepresented graduate students: UAB’s NEURAL Conference

Serving underrepresented graduate students: UAB’s NEURAL Conference

This NIH-funded conference is part of UAB’s effort to engage and retain neuroscience graduate students from underrepresented ethnic and racial groups across the United States.

UAB biomarker outperforms current gold standard to detect brain shunt infections

UAB biomarker outperforms current gold standard to detect brain shunt infections

This is the second potential diagnostic application for an investigational biomarker, and discussions are underway with industry partners to develop an assay from this UAB technology.

Underrepresented students investigate a life in biomedicine with UAB researchers

Underrepresented students investigate a life in biomedicine with UAB researchers
For a second summer, Maria Onatunde traveled to UAB from Florida to participate in UAB's PARAdiGM program, which offers in-depth research experience for undergraduates from disadvantaged and minority backgrounds.

A summer of research at UAB, in eight short weeks

A summer of research at UAB, in eight short weeks
An Iowa college student with dreams of being a physician gleaned invaluable experience and inspiration out of a short summer the intensive research and clinical environment offered through UAB’s Biomedical Sciences Undergraduate Research Program.

Discovery of mechanism that alters neural excitability offers window into neuropsychiatric disease

Discovery of mechanism that alters neural excitability offers window into neuropsychiatric disease
Altered excitability is seen in brain neurons in epilepsy, depression, drug addiction and other disorders, and this discovery may offer a potential therapeutic target.

UAB senior and National Merit Scholar reflects on her time at UAB

UAB senior and National Merit Scholar reflects on her time at UAB

Kelly Walters relishes her access to scientists, clinicians and research opportunities unavailable to undergraduates at many other universities as she builds toward a career in medicine.  

Discovery of infants’ airway microbiomes may help predict lung disease

Discovery of infants’ airway microbiomes may help predict lung disease
UAB researchers have discovered that an infant’s airway — once thought to be sterile until after birth — is colonized by bacteria or bacterial DNA, which could be protective for or predict development of severe lung disease, knowledge that may offer a therapeutic target.

UAB researchers discover why brain neurons in Parkinson’s disease stop benefiting from levodopa

UAB researchers discover why brain neurons in Parkinson’s disease stop benefiting from levodopa
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.

Another elite step in the journey of UAB graduate Bliss Chang

Another elite step in the journey of UAB graduate Bliss Chang
Chang, who was named a 2015 Fulbright Scholar in 2015, is this year one of 57 Phi Kappa Phi fellows selected nationwide.

Discovery may lead to a treatment to slow Parkinson’s disease

Discovery may lead to a treatment to slow Parkinson’s disease
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
Page 42 of 50